Publications by authors named "Heidi D Finnes"

Claim this Profile
P
Pharmacy leadership: Balancing the roles of colleague and manager.
Laura Jean Myhre, Laurel Ann Oetjen, Heidi Diann Finnes, Julie Lynn Cunningham

Am J Health Syst Pharm· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke

Clin Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group.
Heidi D Finnes, Berrie Child, Sean DeFrates, Katharine Kinsman, Andrew Thorne

Am J Health Syst Pharm· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course.
Darragh F O'Donoghue, Huong L Truong, Heidi D Finnes, Jennifer S McDonald, Heather P May

JCO Oncol Pract· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Comprehensive Cancer Network investigational drug service consensus recommendations.
Sapna Amin, Stephen Polley, Sean DeFrates, Heidi D Finnes, Katharine Kinsman

Am J Health Syst Pharm· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management.
Sakti Chakrabarti, Heidi D Finnes, Amit Mahipal

Expert Opin Drug Metab Toxicol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful encorafenib desensitization in a patient with recurrent metastatic melanoma.
Grace D Cullen, Heidi D Finnes, Svetomir N Markovic, Gerald W Volcheck

Melanoma Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2019-2020 Drug Updates in Hematologic Malignancies.
Heidi D Finnes

J Adv Pract Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice.
Amber B Koehler, Nelson Leung, Timothy G Call, Kari G Rabe, Sara J Achenbach, Heidi D Finnes

Leuk Lymphoma· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.
Sameer A Parikh, Sara J Achenbach, Timothy G Call, Kari G Rabe, Wei Ding, Heidi D Finnes

Cancer Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Second-Line Chemotherapy in Extrapulmonary Neuroendocrine Carcinoma.
Patrick W McGarrah, Konstantinos Leventakos, Timothy J Hobday, Julian R Molina, Heidi D Finnes

Pancreas· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral CD3 and CD8 T-Cell Densities in Patients With DNA Mismatch Repair-Deficient Metastatic Colorectal Cancer Receiving Programmed Cell Death-1 Blockade.
Sakti Chakrabarti, Lucas J Huebner, Heidi D Finnes, Andrea Muranyi, June Clements

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single-Center Cohort of Sixty-One Patients.
Michael D Richter, Cynthia Crowson, Lisa A Kottschade, Heidi D Finnes, Svetomir N Markovic

Arthritis Rheumatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience.
Michael D Richter, Olga Pinkston, Lisa A Kottschade, Heidi D Finnes, Svetomir N Markovic

Arthritis Rheumatol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma.
Jan B Egan, David L Marks, Tara L Hogenson, Anne M Vrabel, Ashley N Sigafoos, Heidi D Finnes

JCO Precis Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice.
Heidi D Finnes, Kari G Chaffee, Timothy G Call, Wei Ding, Saad S Kenderian

Leuk Lymphoma· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and dose adjustment of cyclophosphamide in lymphoma patients requiring hemodialysis.
Abdurrahman M Hamadah, Gita Thanarajasingam, Kamel A Gharaibeh, Heidi D Finnes, Carrie A Thompson

Leuk Lymphoma· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma.
Jarrett J Failing, Heidi D Finnes, Lisa A Kottschade, Jacob B Allred, Svetomir N Markovic

Melanoma Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab-induced colitis in patients with metastatic melanoma.
Kara M De Felice, Arjun Gupta, Sagar Rakshit, Sahil Khanna, Lisa A Kottschade, Heidi D Finnes

Melanoma Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer.
Pashtoon Murtaza Kasi, Gita Thanarajasingam, Heidi D Finnes, Jose C Villasboas Bisneto, Joleen M Hubbard

Case Rep Oncol Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels.
Tait D Shanafelt, Bijan J Borah, Heidi D Finnes, Kari G Chaffee, Wei Ding

J Oncol Pract· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-drug interaction between bosutinib and warfarin.
Ashish V Chintakuntlawar, Heidi D Finnes, Ayalew Tefferi, Animesh Pardanani

Leuk Lymphoma· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis